...
首页> 外文期刊>Pediatric nephrology: journal of the International Pediatric Nephrology Association >Successful treatment of gastrointestinal involvement in Henoch-Schonlein purpura with plasmapheresis.
【24h】

Successful treatment of gastrointestinal involvement in Henoch-Schonlein purpura with plasmapheresis.

机译:血浆置换术治疗成功的过敏性紫癜胃肠道受累。

获取原文
获取原文并翻译 | 示例

摘要

Sir, We report on severe gastrointestinal bleeding that was successfully treated with four sessions of plasmapheresis. In a 13-year-old girl, Henoch-Schonlein purpura (HSP) was diagnosed 5 year earlier following a vaccination against hepatitis B [1]. This time, 2 days after hepatitis B revaccination, necrotizing purpura started on lower extremities and spread throughout the body, including the face. Urinary protein excretion was 4.2 mg/m~2/h, but serum creatinine was not elevated. A skin biopsy showed perivascular deposits of immunoglobulin A (IgA) when using direct immunofluorescence. After three pulses of methylprednisolone (30 mg/kg), 2 mg/kg prednisolone treatment was given because of necrotizing purpuric lesions. Although she was using steroids, in next 15 days, she twice had severe gastrointestinal bleeding. Her hemoglobin dropped from 14.3 to 10.2 g/dl. As she had repeated gastrointestinal bleedings 800 mg/m~2 intravenous immunoglobulin was infused, but necrotizing purpura at the lower limbs and gastrointestinal hemorrhage recurred after 5 days of well-being. Treatment with 500 mg/m~2 cyclophosphamide at day 25 of the disease did not stop gastrointestinal bleeding. Therefore, we started four sessions of plasmapheresis. A total of 800 ml of human plasma was exchanged per cycle on alternate days. Cutaneous lesions were resolved 48 h after the start of plasmapheresis, and no gastrointestinal bleeding was noted thereafter. After the plasmapheresis, low-dose steroid treatment was given in alternate-day cycle during the second month of the disease. Two months after discharge, she had no complaints, physical examination was normal, and laboratory parameters were in the normal range. In conclusion, we feel that plasma exchange might be an effective therapy in patients with HSP presenting severe symptoms, including severe gastrointestinal symptoms [2-4].
机译:主席先生,我们报告了四次血浆置换成功治疗的严重胃肠道出血。一名13岁女孩在接受乙型肝炎疫苗接种后5年前被诊断出过敏性紫癜(HSP)[1]。这次是在乙肝疫苗接种2天后,下肢坏死性紫癜开始出现,并蔓延至全身,包括面部。尿蛋白排泄为4.2 mg / m〜2 / h,但血清肌酐并未升高。当使用直接免疫荧光法时,皮肤活检显示免疫球蛋白A(IgA)在血管周围沉积。在三脉冲甲基强的松龙(30 mg / kg)后,由于坏死性紫癜性病变,给予泼尼松龙2 mg / kg的治疗。尽管她正在使用类固醇,但在接下来的15天中,她两次出现了严重的胃肠道出血。她的血红蛋白从14.3 g / dl下降到10.2 g / dl。由于她反复出现胃肠道出血,因此静脉输注了800 mg / m〜2的免疫球蛋白,但下肢坏死性紫癜和健康5天后再次出现胃肠道出血。在疾病的第25天用500 mg / m〜2的环磷酰胺治疗并没有停止胃肠道出血。因此,我们开始了四次血浆置换。每个周期在隔天更换总共800毫升的人血浆。血浆置换开始后48小时皮肤病灶消失,此后未发现胃肠道出血。血浆置换后,在疾病第二个月的隔日循环中进行低剂量类固醇治疗。出院后两个月,她没有任何不适,体格检查正常,实验室参数在正常范围内。总之,我们认为血浆置换可能是具有严重症状(包括严重胃肠道症状)的HSP患者的有效疗法[2-4]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号